Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Targosz BS"'
Autor:
Eichner R; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Fernández-Sáiz V; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Targosz BS; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Bassermann F; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
International review of cell and molecular biology [Int Rev Cell Mol Biol] 2019; Vol. 343, pp. 219-297. Date of Electronic Publication: 2018 Aug 10.
Autor:
Engel K; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany., Rudelius M; Institute of Pathology and Comprehensive Cancer Center Mainfranken, Universität Würzburg, Würzburg, Germany., Slawska J; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany., Jacobs L; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany., Ahangarian Abhari B; Institut für Experimentelle Tumorforschung in der Pädiatrie, Goethe-Universität Frankfurt, Frankfurt am Main, Germany., Altmann B; Institute for Medical Informatics, Statistics and Epidemiology, Universität Leipzig, Leipzig, Germany., Kurutz J; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany., Rathakrishnan A; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany., Fernández-Sáiz V; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Brunner A; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany., Targosz BS; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany., Loewecke F; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany., Gloeckner CJ; Eberhard-Karls-Universität Tübingen, Institute for Ophthalmic Research, Medical Proteome Center, Tübingen, Germany German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany., Ueffing M; Eberhard-Karls-Universität Tübingen, Institute for Ophthalmic Research, Medical Proteome Center, Tübingen, Germany., Fulda S; Institut für Experimentelle Tumorforschung in der Pädiatrie, Goethe-Universität Frankfurt, Frankfurt am Main, Germany German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Pfreundschuh M; Department of Medicine I, Saarland University Medical School, Homburg (Saar), Germany., Trümper L; Department of Hematology and Oncology, Georg-August-Universität Göttingen, Göttingen, Germany., Klapper W; Institute of Pathology, Haematopathology Section and Lymph Node Registry, Universitätsklinikum Schleswig-Holstein, Kiel, Germany., Keller U; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Jost PJ; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany., Rosenwald A; Institute of Pathology and Comprehensive Cancer Center Mainfranken, Universität Würzburg, Würzburg, Germany., Peschel C; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Bassermann F; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany florian.bassermann@tum.de.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2016 Aug 01; Vol. 8 (8), pp. 851-62. Date of Electronic Publication: 2016 Aug 01 (Print Publication: 2016).
Autor:
Eichner R; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Heider M; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Fernández-Sáiz V; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., van Bebber F; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Garz AK; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Lemeer S; Department of Proteomics and Bioanalytics, Technische Universität München, Freising, Germany., Rudelius M; Institute of Pathology, Universität Würzburg, Würzburg, Germany.; Comprehensive Cancer Center Mainfranken, Universität Würzburg, Würzburg, Germany., Targosz BS; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Jacobs L; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Knorn AM; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Slawska J; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Platzbecker U; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl-Gustav-Carus, Technische Universität, Dresden, Germany., Germing U; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany., Langer C; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Knop S; Division of Hematology and Medical Oncology, Department of Internal Medicine II, Würzburg University Medical Center, Würzburg, Germany., Einsele H; Division of Hematology and Medical Oncology, Department of Internal Medicine II, Würzburg University Medical Center, Würzburg, Germany., Peschel C; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Haass C; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Biomedical Center, Ludwig-Maximilians University Munich, Munich, Germany., Keller U; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Schmid B; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Götze KS; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Kuster B; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Proteomics and Bioanalytics, Technische Universität München, Freising, Germany.; Center for Integrated Protein Science Munich (CIPSM), Freising, Germany., Bassermann F; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Nature medicine [Nat Med] 2016 Jul; Vol. 22 (7), pp. 735-43. Date of Electronic Publication: 2016 Jun 13.
Autor:
Baumann U; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany., Fernández-Sáiz V; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany., Rudelius M; Institute of Pathology, Julius-Maximilians-University and Comprehensive Cancer Center Mainfranken, Wuerzburg, Germany., Lemeer S; Department of Proteomics and Bioanalytics, Technische Universität München, Freising, Germany., Rad R; 1] Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany. [2] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Knorn AM; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany., Slawska J; Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany., Engel K; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany., Jeremias I; 1] Department of Gene Vectors, Helmholtz Center Munich-German Research Center for Environmental Health, Munich, Germany. [2] Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilians University, Munich, Germany., Li Z; Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany., Tomiatti V; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany., Illert AL; Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany., Targosz BS; Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany., Braun M; Department of Prostate Cancer Research, Institute of Pathology, University Hospital of Bonn, Bonn, Germany., Perner S; Department of Prostate Cancer Research, Institute of Pathology, University Hospital of Bonn, Bonn, Germany., Leitges M; Biotechnology Centre of Oslo, Oslo, Norway., Klapper W; Institute of Pathology, Hematopathology Section and Lymph Node Registry, Universitätsklinikum Schleswig-Holstein, Kiel, Germany., Dreyling M; Department of Medicine III, University Hospital Munchen, Munich, Germany., Miething C; Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany., Lenz G; Translational Oncology, Department of Medicine A, Universitätsklinikum Münster, Münster, Germany., Rosenwald A; Institute of Pathology, Julius-Maximilians-University and Comprehensive Cancer Center Mainfranken, Wuerzburg, Germany., Peschel C; 1] Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany. [2] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Keller U; 1] Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany. [2] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Kuster B; 1] Department of Proteomics and Bioanalytics, Technische Universität München, Freising, Germany. [2] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. [3] Center for Integrated Protein Science Munich (CIPSM), Freising, Germany., Bassermann F; 1] Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany. [2] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Nature medicine [Nat Med] 2014 Dec; Vol. 20 (12), pp. 1401-9. Date of Electronic Publication: 2014 Nov 24.
Autor:
Fernández-Sáiz V; Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany., Targosz BS, Lemeer S, Eichner R, Langer C, Bullinger L, Reiter C, Slotta-Huspenina J, Schroeder S, Knorn AM, Kurutz J, Peschel C, Pagano M, Kuster B, Bassermann F
Publikováno v:
Nature cell biology [Nat Cell Biol] 2013 Jan; Vol. 15 (1), pp. 72-81.
Autor:
Nkosi PJ; Paterson Institute for Cancer Research, University of Manchester, Manchester, United Kingdom., Targosz BS, Labib K, Sanchez-Diaz A
Publikováno v:
PloS one [PLoS One] 2013; Vol. 8 (2), pp. e57846. Date of Electronic Publication: 2013 Feb 28.
Autor:
Ditzen C; Max Planck Institute of Psychiatry, Munich, Germany., Varadarajulu J, Czibere L, Gonik M, Targosz BS, Hambsch B, Bettecken T, Kessler MS, Frank E, Bunck M, Teplytska L, Erhardt A, Holsboer F, Müller-Myhsok B, Landgraf R, Turck CW
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2010 Jul; Vol. 15 (7), pp. 702-11. Date of Electronic Publication: 2009 Jan 13.
Autor:
Palagyi A; Department of Medicine II, Ludwig-Maximilians-University, Campus Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany., Neveling K, Plinninger U, Ziesch A, Targosz BS, Denk GU, Ochs S, Rizzani A, Meier D, Thasler WE, Hanenberg H, De Toni EN, Bassermann F, Schäfer C, Göke B, Schindler D, Gallmeier E
Publikováno v:
Molecular cancer [Mol Cancer] 2010 May 28; Vol. 9, pp. 127. Date of Electronic Publication: 2010 May 28.
Autor:
Sadoni N; Department of Biology II, Ludwig-Maximilians-University Munich, Biocenter, Planegg-Martinsried, Germany., Targosz BS, Englmann A, Fesser S, Koch J, Schindelhauer D, Zink D
Publikováno v:
Chromosoma [Chromosoma] 2008 Aug; Vol. 117 (4), pp. 381-97. Date of Electronic Publication: 2008 Apr 12.
Autor:
Ditzen C; Max Planck Institute of Psychiatry, D-80804 Munich, Germany., Jastorff AM, Kessler MS, Bunck M, Teplytska L, Erhardt A, Krömer SA, Varadarajulu J, Targosz BS, Sayan-Ayata EF, Holsboer F, Landgraf R, Turck CW
Publikováno v:
Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2006 Oct; Vol. 5 (10), pp. 1914-20. Date of Electronic Publication: 2006 Jun 14.